Richard Pzena Gilead Sciences, Inc. Transaction History

Pzena Investment Management LLC

$30.2 Billion
Q3 2024

A detailed history of Richard Pzena (Pzena Investment Management LLC) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pzena Investment Management LLC holds 2,624 shares of GILD stock, worth $246,708. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,624

Previous 4,589 42.82%

Holding current value

$246,708

Previous $314,000 30.25%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$66.59 - $83.99 $130,849 - $165,040	-1,965 Reduced 42.82%	2,624 $219,000
Q2 2024 Aug 02, 2024	SELL	$63.15 - $72.88 $103,629 - $119,596	-1,641 Reduced 26.34%	4,589 $314,000
Q1 2024 May 03, 2024	BUY	$71.58 - $87.29 $25,697 - $31,337	359 Added 6.11%	6,230 $456,000
Q4 2023 Feb 09, 2024	SELL	$73.27 - $83.09 $9,525 - $10,801	-130 Reduced 2.17%	5,871 $475,000
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $4,140 - $4,517	56 Added 0.94%	6,001 $449,000
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $178,699 - $203,831	2,351 Added 65.41%	5,945 $458,000
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $277,852 - $316,559	3,594 New	3,594 $298,000
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $197,159 - $247,062	-3,404 Closed	0 $0
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $306,233 - $347,580	-4,720 Reduced 58.1%	3,404 $247,000
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $250,453 - $270,211	3,700 Added 83.63%	8,124 $567,000
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $373,267 - $407,847	-5,881 Reduced 57.07%	4,424 $305,000
Q1 2021 May 07, 2021	BUY	$60.0 - $68.46 $13,920 - $15,882	232 Added 2.3%	10,305 $666,000
Q4 2020 Feb 05, 2021	BUY	$56.65 - $64.55 $111,487 - $127,034	1,968 Added 24.28%	10,073 $587,000
Q3 2020 Oct 30, 2020	BUY	$62.1 - $78.08 $503,320 - $632,838	8,105 New	8,105 $512,000
Q1 2020 May 01, 2020	SELL	$62.63 - $80.22 $474,798 - $608,147	-7,581 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$62.51 - $69.0 $473,888 - $523,089	7,581 New	7,581 $480,000
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $204,129 - $239,618	-2,869 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $206,883 - $245,213	2,869	2,869 $232,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track Richard Pzena's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.

Account